Results 231 to 240 of about 193,022 (330)
N‐terminal pro brain natriuretic peptide in the management of patients in the medical emergency department (PROMPT): correlation with disease severity, utilization of hospital resources, and prognosis in a large, prospective, randomized multicentre trial
European Journal of Heart Failure, 2012 A. Luchner, M. Möckel, E. Spanuth, J. Möcks, D. Peetz, H. Baum, C. Spes, C. Wrede, J. Vollert, R. Müller, H. Katus, E. Giannitsis +11 moresemanticscholar +1 more sourceInterconnected pathways and emerging therapies in chronic kidney disease and heart failure: A comprehensive review
ESC Heart Failure, EarlyView.Abstract
Chronic kidney disease (CKD) and chronic heart failure (HF) frequently coexist and, when comorbid, are associated with poorer outcomes. These two diseases have common risk factors, such as diabetes, obesity and hypertension, and common pathophysiological connected mechanisms, including inflammation, endothelial dysfunction, neurohormonal ...Johann Bauersachs, Eri Toda Kato, Janani Rangaswami +2 morewiley +1 more sourcePrevalence of high N-terminal prohormone of brain natriuretic peptide levels and associated factors among community-dwelling older adults aged over 75 years (The SONIC study): a cross-sectional study. [PDF]
BMC Res NotesTerada S, Godai K, Kabayama M, Kido M, Akagi Y, Akasaka H, Takami Y, Nakagawa T, Yasumoto S, Gondo Y, Ikebe K, Arai Y, Masui Y, Hirata T, Yamamoto K, Kamide K. +15 moreeuropepmc +1 more sourceAssociation of baseline and longitudinal changes in insulin‐like growth factor‐binding protein‐7 with the risk of incident heart failure: Data from the PREVEND study
European Journal of Heart Failure, EarlyView.Insulin‐like growth factor‐binding protein‐7 (IGFBP7) and heart failure (HF) risk: the PREVEND study. CI, confidence interval; HR, hazard ratio. Abstract Aim
Senescence is a major risk factor for heart failure (HF), and insulin‐like growth factor‐binding protein‐7 (IGFBP7) has been identified as an important senescence‐inducing factor.Sabrina Abou Kamar, Valentina Bracun, Maissa El‐Qendouci, Nils Bomer, Stephan J.L. Bakker, Ron T. Gansevoort, Eric Boersma, Isabella Kardys, Rudolf A. de Boer, Navin Suthahar +9 morewiley +1 more sourceQuality of life in heart failure. The heart of the matter. A scientific statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of Cardiology
European Journal of Heart Failure, EarlyView.For most patients with chronic, progressive illnesses, maintaining good quality of life (QoL), with preserved functional capacity, is just as crucial as prolonging survival. Patients with heart failure (HF) experience much worse QoL and effort intolerance than both the general population and people with other chronic conditions, since they present a ...Maurizio Volterrani, Geza Halasz, Stamatis Adamopoulos, Pier Giuseppe Agostoni, Javed Butler, Andrew J.S. Coats, Alan Cohen‐Solal, Wolfram Doehner, Gerasimos Filippatos, Ewa Jankowska, Carolyn S.P. Lam, Ekaterini Lambrinou, Lars H. Lund, Giuseppe Rosano, Marco Metra, Stefania Paolillo, Pasquale Perrone Filardi, Amina Rakisheva, Gianluigi Savarese, Petar Seferovic, Carlo Gabriele Tocchetti, Massimo Piepoli +21 morewiley +1 more sourceFurosemide‐hydration matching with RenalGuard® in decompensated heart failure: an alternative way to use diuretics and saline
ESC Heart Failure, EarlyView.Massimo Mapelli, Filippo Maria Rubbo, Jeness Campodonico, Nicola Cosentino, Giancarlo Marenzi, Valentina Mantegazza, Filippo Trombara, Mateusz Sokolski, Piotr Ponikowski, Piergiuseppe Agostoni +9 morewiley +1 more sourceMicrovascular obstruction in cardiac amyloidosis
European Journal of Heart Failure, EarlyView.Abstract Aims
Cardiac amyloidosis (CA) is characterized by deposition of amyloid fibrils within the extracellular space, causing disarray of the myocardial structure and capillary architecture. This study aims to characterize the prevalence of microvascular obstruction (MVO) in patients with CA and to assess the association between MVO and prognosis ...Lucrezia Netti, Adam Ioannou, Ana Martinez‐Naharro, Yousuf Razvi, Aldostefano Porcari, Lucia Venneri, Viviana Maestrini, Dan Knight, Ruta Virsinskaite, Muhammad U. Rauf, Tushar Kotecha, Rishi K. Patel, Ashutosh Wechelakar, Helen Lachmann, Peter Kellman, Charlotte Manisty, James Moon, Philip N. Hawkins, Julian D. Gillmore, Marianna Fontana +19 morewiley +1 more sourceComparison of Natriuretic Peptide Levels in Sinus Rhythm and Atrial Fibrillation in Acute Heart Failure. [PDF]
Int J Heart FailYoon M, Park JJ, Youn JC, Lee SE, Lee HY, Choi JO, Kim KH, Yang DH, Cho MC, Kang SM, Yoo BS. +10 moreeuropepmc +1 more sourceAtrial natiuretic peptid in normal humans: Hemodynamic and renal effects after single and repeated bolus injection [PDF]
, 1989 Ball, P., Brenner, Barry M., Gerzer, R., Kentsch, M., Klohs, S., Lawrenz, R., Müller-Esch, G., Potratz, J., Scriba, Peter Christian +8 morecore